Brivaracetam
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/17/2019
Pipeline Type
Newly Marketed
Phase Of Development
Sponsors and Collaborators
Mechanism of Action
Mechanism Description
Interacts with Synaptic Vesicle 2A
Populations Tested In
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Location of Clinical Trials
Clinical Trial link